Inflammation and host-pathogen interaction: Cause and consequence in cystic fibrosis lung disease

A Bragonzi, H Horati, L Kerrigan, NI Lorè, BJ Scholte, S Weldon

Research output: Contribution to journalArticle

Abstract

Cystic Fibrosis (CF) lung disease is associated with dysregulation of host defence systems, which ultimately disrupts the balance between inflammation and resolution and leaves the host susceptible to repeated infection. However, the mechanisms underlying these defects are complex and continue to garner significant interest among the CF research community. This review explores emerging data on novel aspects of innate host defence with promising biomarker and therapeutic potential for CF lung disease. Improved understanding of inflammation and host defence against pathogens in patients and animal models during the progression of CF lung disease is pivotal for the discovery of new therapeutics that can limit and/or prevent damage from birth. © 2017 European Cystic Fibrosis Society.
Original languageEnglish
Pages (from-to)S40–S45
JournalJournal of Cystic Fibrosis
Issue number17(2 Suppl
DOIs
Publication statusPublished - 2018

Fingerprint

Host-Pathogen Interactions
Cystic Fibrosis
Lung Diseases
Inflammation
Animal Models
Biomarkers
Parturition
Therapeutics
Infection
Research

Cite this

Inflammation and host-pathogen interaction: Cause and consequence in cystic fibrosis lung disease. / Bragonzi, A; Horati, H; Kerrigan, L; Lorè, NI; Scholte, BJ; Weldon, S.

In: Journal of Cystic Fibrosis, No. 17(2 Suppl, 2018, p. S40–S45.

Research output: Contribution to journalArticle

Bragonzi, A ; Horati, H ; Kerrigan, L ; Lorè, NI ; Scholte, BJ ; Weldon, S. / Inflammation and host-pathogen interaction: Cause and consequence in cystic fibrosis lung disease. In: Journal of Cystic Fibrosis. 2018 ; No. 17(2 Suppl. pp. S40–S45.
@article{c092a6db4ef843baba6e4c1bd8248098,
title = "Inflammation and host-pathogen interaction: Cause and consequence in cystic fibrosis lung disease",
abstract = "Cystic Fibrosis (CF) lung disease is associated with dysregulation of host defence systems, which ultimately disrupts the balance between inflammation and resolution and leaves the host susceptible to repeated infection. However, the mechanisms underlying these defects are complex and continue to garner significant interest among the CF research community. This review explores emerging data on novel aspects of innate host defence with promising biomarker and therapeutic potential for CF lung disease. Improved understanding of inflammation and host defence against pathogens in patients and animal models during the progression of CF lung disease is pivotal for the discovery of new therapeutics that can limit and/or prevent damage from birth. {\circledC} 2017 European Cystic Fibrosis Society.",
author = "A Bragonzi and H Horati and L Kerrigan and NI Lor{\`e} and BJ Scholte and S Weldon",
year = "2018",
doi = "10.1016/j.jcf.2017.10.004",
language = "English",
pages = "S40–S45",
journal = "Journal of Cystic Fibrosis",
issn = "1569-1993",
publisher = "Elsevier",
number = "17(2 Suppl",

}

TY - JOUR

T1 - Inflammation and host-pathogen interaction: Cause and consequence in cystic fibrosis lung disease

AU - Bragonzi, A

AU - Horati, H

AU - Kerrigan, L

AU - Lorè, NI

AU - Scholte, BJ

AU - Weldon, S

PY - 2018

Y1 - 2018

N2 - Cystic Fibrosis (CF) lung disease is associated with dysregulation of host defence systems, which ultimately disrupts the balance between inflammation and resolution and leaves the host susceptible to repeated infection. However, the mechanisms underlying these defects are complex and continue to garner significant interest among the CF research community. This review explores emerging data on novel aspects of innate host defence with promising biomarker and therapeutic potential for CF lung disease. Improved understanding of inflammation and host defence against pathogens in patients and animal models during the progression of CF lung disease is pivotal for the discovery of new therapeutics that can limit and/or prevent damage from birth. © 2017 European Cystic Fibrosis Society.

AB - Cystic Fibrosis (CF) lung disease is associated with dysregulation of host defence systems, which ultimately disrupts the balance between inflammation and resolution and leaves the host susceptible to repeated infection. However, the mechanisms underlying these defects are complex and continue to garner significant interest among the CF research community. This review explores emerging data on novel aspects of innate host defence with promising biomarker and therapeutic potential for CF lung disease. Improved understanding of inflammation and host defence against pathogens in patients and animal models during the progression of CF lung disease is pivotal for the discovery of new therapeutics that can limit and/or prevent damage from birth. © 2017 European Cystic Fibrosis Society.

U2 - 10.1016/j.jcf.2017.10.004

DO - 10.1016/j.jcf.2017.10.004

M3 - Article

SP - S40–S45

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

IS - 17(2 Suppl

ER -